Replication of brain function effects of a genome-wide supported psychiatric risk variant in the CACNA1C gene and new multi-locus effects

NeuroImage

Volumn 94, Issue , 2014, Pages 147-154

  Erk, Susanne ^a   Meyer Lindenberg, Andreas ^c   Linden, David E J ^d   Lancaster, Thomas ^d   Mohnke, Sebastian ^a   Grimm, Oliver ^c   Degenhardt, Franziska ^e   Holmans, Peter ^d   Pocklington, Andrew ^d   Schmierer, Phöbe ^a,b   Haddad, Leila ^c   Mühleisen, Thomas W ^e,f   Mattheisen, Manuel ^g   Witt, Stephanie H ^c   Romanczuk Seiferth, Nina ^a   Tost, Heike ^c   Schott, Björn H ^a   Cichon, Sven ^e,h   Nöthen, Markus M ^e   Rietschel, Marcella ^c   Heinz, Andreas ^a   Walter, Henrik ^a,b,e   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF BONN   (Germany)

^f FORSCHUNGSZENTRUM JÜLICH   (Germany)

^g AARHUS UNIVERSITY   (Denmark)

^h UNIVERSITY OF BASEL   (Switzerland)

Author keywords

CACNA1C; Dorsolateral prefrontal cortex; FMRI; Hippocampus; Imaging genetics; Perigenual anterior cingulate

Indexed keywords

ADULT; ANTERIOR CINGULATE; ARTICLE; ASSOCIATIVE MEMORY; BRAIN FUNCTION; CACNA1C GENE; COHORT ANALYSIS; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; GENE; GENE LOCUS; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPUS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHENOTYPE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGIC TEST; BRAIN; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; NERVE CELL NETWORK; PATHOPHYSIOLOGY; PSYCHOSIS; RISK ASSESSMENT;

CACNA1C PROTEIN, HUMAN; CALCIUM CHANNEL L TYPE;

ADULT; BRAIN; CALCIUM CHANNELS, L-TYPE; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MEMORY, EPISODIC; NERVE NET; PSYCHOTIC DISORDERS; RISK ASSESSMENT;

EID: 84898647391     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.03.007     Document Type: Article

References (65)

1. Abbott A. Psychiatric genetics: the brains of the family. Nature 2008, 454:154-157.
2. Anderson M.C., Ochsner K.N., Kuhl B., Cooper J., Robertson E., Gabrieli S.W., Glover G.H., Gabrieli J.D. Neural systems underlying the suppression of unwanted memories. Science 2004, 303:232-235.
3. Bhat S., Dao D.T., Terrillion C.E., Arad M., Smith R.J., Soldatov N.M., Gould T.D. CACNA1C (Ca(v)1.2) in the pathophysiology of psychiatric disease. Prog. Neurobiol. 2012, 99:1-14.
4. Bigos K.L., Mattay V.S., Callicott J.H., Straub R.E., Vakkalanka R., Kolachana B., Hyde T.M., Lipska B.K., Kleinman J.E., Weinberger D.R. Genetic variation in CACNA1C affects brain circuitries related to mental illness. Arch. Gen. Psychiatry 2010, 67:939-945.
5. Chameau P., Qin Y., Spijker S., Smit A.B., Joels M. Glucocorticoids specifically enhance l-type calcium current amplitude and affect calcium channel subunit expression in the mouse hippocampus. J. Neurophysiol. 2007, 97:5-14.
6. Chen C.H., Suckling J., Lennox B.R., Ooi C., Bullmore E.T. A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord. 2011, 13:1-15.
7. Craddock N., O'Donovan M.C., Owen M.J. Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses. Schizophr. Bull. 2009, 35:482-490.
8. de Kloet E.R., Joels M., Holsboer F. Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 2005, 6:463-475.
9. Depue B.E., Curran T., Banich M.T. Prefrontal regions orchestrate suppression of emotional memories via a two-phase process. Science 2007, 317:215-219.
10. Dietsche B., Backes H., Laneri D., Weikert T., Witt S.H., Rietschel M., Sommmer J., Kircher T., Krug A. The impact of a CACNA1C gene polymorphism on learning and hippocampal formation in healthy individuals: a diffusion tensor imaging study. Neuroimage 2014, 89:256-261.
11. Dima D., Jogia J., Collier D., Vassos E., Burdick K.E., Frangou S. Independent modulation of engagement and connectivity of the facial network during affect processing by CACNA1C and ANK3 risk genes for bipolar disorder. JAMA Psychiatry 2013, 70:1303-1311.
12. Dudbridge F. Power and predictive accuracy of polygenic risk scores. PLoS Genet. 2013, 9:e1003348.
13. Erk S., Meyer-Lindenberg A., Schnell K., Opitz von Boberfeld C., Esslinger C., Kirsch P., Grimm O., Arnold C., Haddad L., Witt S.H., Cichon S., Nothen M.M., Rietschel M., Walter H. Brain function in carriers of a genome-wide supported bipolar disorder variant. Arch. Gen. Psychiatry 2010, 67:803-811.
14. Erk S., Meyer-Lindenberg A., Schmierer P., Mohnke S., Grimm O., Garbusow M., Haddad L., Poehland L., Muhleisen T.W., Witt S.H., Tost H., Kirsch P., Romanczuk-Seiferth N., Schott B.H., Cichon S., Nothen M.M., Rietschel M., Heinz A., Walter H. Hippocampal and frontolimbic function as intermediate phenotype for psychosis: evidence from healthy relatives and a common risk variant in CACNA1C. Biol. Psychiatry 2014, (in press). 10.1016/j.biopsych.2013.11.025.
15. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., Fan J., Kirov G., Perlis R.H., Green E.K., Smoller J.W., Grozeva D., Stone J., Nikolov I., Chambert K., Hamshere M.L., Nimgaonkar V.L., Moskvina V., Thase M.E., Caesar S., Sachs G.S., Franklin J., Gordon-Smith K., Ardlie K.G., Gabriel S.B., Fraser C., Blumenstiel B., Defelice M., Breen G., Gill M., Morris D.W., Elkin A., Muir W.J., McGhee K.A., Williamson R., MacIntyre D.J., MacLean A.W., St C.D., Robinson M., Van Beck M., Pereira A.C., Kandaswamy R., McQuillin A., Collier D.A., Bass N.J., Young A.H., Lawrence J., Ferrier I.N., Anjorin A., Farmer A., Curtis D., Scolnick E.M., McGuffin P., Daly M.J., Corvin A.P., Holmans P.A., Blackwood D.H., Gurling H.M., Owen M.J., Purcell S.M., Sklar P., Craddock N. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat. Genet. 2008, 40:1056-1058.
16. Frey B.N., Andreazza A.C., Nery F.G., Martins M.R., Quevedo J., Soares J.C., Kapczinski F. The role of hippocampus in the pathophysiology of bipolar disorder. Behav. Pharmacol. 2007, 18:419-430.
17. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160:636-645.
18. Gottesman I.I., Shields J. A polygenic theory of schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 1967, 58:199-205.
19. Green E.K., Grozeva D., Jones I., Jones L., Kirov G., Caesar S., Gordon-Smith K., Fraser C., Forty L., Russell E., Hamshere M.L., Moskvina V., Nikolov I., Farmer A., McGuffin P., Holmans P.A., Owen M.J., O'Donovan M.C., Craddock N. The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 2010, 15:1016-1022.
20. Green E.K., Hamshere M., Forty L., Gordon-Smith K., Fraser C., Russell E., Grozeva D., Kirov G., Holmans P., Moran J.L., Purcell S., Sklar P., Owen M.J., O'Donovan M.C., Jones L., Jones I.R., Craddock N. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case-control sample. Mol. Psychiatry 2013, 18:1302-1307.
21. Hamshere M.L., Walters J.T., Smith R., Richards A.L., Green E., Grozeva D., Jones I., Forty L., Jones L., Gordon-Smith K., Riley B., O'Neill T., Kendler K.S., Sklar P., Purcell S., Kranz J., Morris D., Gill M., Holmans P., Craddock N., Corvin A., Owen M.J., O'Donovan M.C. Genome-wide significant associations in schizophrenia to ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations reported by the Schizophrenia PGC. Mol. Psychiatry 2013, 18:708-712.
22. Harrison P.J., Eastwood S.L. Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 2001, 11:508-519.
23. Hasler G., Drevets W.C., Gould T.D., Gottesman I.I., Manji H.K. Toward constructing an endophenotype strategy for bipolar disorders. Biol. Psychiatry 2006, 60:93-105.
24. Heckers S., Konradi C. Hippocampal pathology in schizophrenia. Curr. Top. Behav. Neurosci. 2010, 4:529-553.
25. Israel S.L., Seibert T.M., Black M.L., Brewer J.B. Going their separate ways: dissociation of hippocampal and dorsolateral prefrontal activation during episodic retrieval and post-retrieval processing. J. Cogn. Neurosci. 2010, 22:513-525.
26. Joels M., Karst H. Corticosteroid effects on calcium signaling in limbic neurons. Cell Calcium 2012, 51:277-283.
27. Jogia J., Ruberto G., Lelli-Chiesa G., Vassos E., Maieru M., Tatarelli R., Girardi P., Collier D., Frangou S. The impact of the CACNA1C gene polymorphism on frontolimbic function in bipolar disorder. Mol. Psychiatry 2011, 16:1070-1071.
28. Keers R., Farmer A.E., Aitchison K.J. Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable finding. Psychol. Med. 2009, 39:1231-1235.
29. Krug A., Witt S.H., Backes H., Dietsche B., Nieratschker V., Jon Shah N., Nöthen M., Rietschel M., Kircher T. A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval. Eur. Arch. Psychiatry Clin. Neurosci. 2014, 264:103-110.
30. Lee A.S., Ra S., Rajadhyaksha A.M., Britt J.K., De Jesus-Cortes H., Gonzales K.L., Lee A., Moosmang S., Hofmann F., Pieper A.A. Forebrain elimination of cacna1c mediates anxiety-like behavior in mice. Mol. Psychiatry 2012, 17:1054-1055.
31. Lett T.A., Zai C.C., Tiwari A.K., Shaikh S.A., Likhodi O., Kennedy J.L., Muller D.J. ANK3, CACNA1C and ZNF804A gene variants in bipolar disorders and psychosis subphenotype. World J. Biol. Psychiatry 2011, 12:392-397.
32. Levy N.A., Janicak P.G. Calcium channel antagonists for the treatment of bipolar disorder. Bipolar Disord. 2000, 2:108-119.
33. Liu Y., Blackwood D.H., Caesar S., de Geus E.J., Farmer A., Ferreira M.A., Ferrier I.N., Fraser C., Gordon-Smith K., Green E.K., Grozeva D., Gurling H.M., Hamshere M.L., Heutink P., Holmans P.A., Hoogendijk W.J., Hottenga J.J., Jones L., Jones I.R., Kirov G., Lin D., McGuffin P., Moskvina V., Nolen W.A., Perlis R.H., Posthuma D., Scolnick E.M., Smit A.B., Smit J.H., Smoller J.W., St Clair D., van Dyck R., Verhage M., Willemsen G., Young A.H., Zandbelt T., Boomsma D.I., Craddock N., O'Donovan M.C., Owen M.J., Penninx B.W., Purcell S., Sklar P., Sullivan P.F. Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder. Mol. Psychiatry 2011, 16:2-4.
34. MacQueen G., Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?. Mol. Psychiatry 2011, 16:252-264.
35. McEwen B.S. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. N. Y. Acad. Sci. 2001, 933:265-277.
36. McEwen B.S., Magarinos A.M. Stress and hippocampal plasticity: implications for the pathophysiology of affective disorders. Hum Psychopharmacol 2001, 16:S7-S19.
37. Meyer-Lindenberg A. Neuroimaging and the question of neurodegeneration in schizophrenia. Prog. Neurobiol. 2011, 95:514-516.
38. Meyer-Lindenberg A., Tost H. Neural mechanisms of social risk for psychiatric disorders. Nat. Neurosci. 2012, 15:663-668.
39. Meyer-Lindenberg A., Weinberger D.R. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat. Rev. Neurosci. 2006, 7:818-827.
40. Moosmang S., Haider N., Klugbauer N., Adelsberger H., Langwieser N., Muller J., Stiess M., Marais E., Schulla V., Lacinova L., Goebbels S., Nave K.A., Storm D.R., Hofmann F., Kleppisch T. Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J. Neurosci. 2005, 25:9883-9892.
41. Moskvina V., Craddock N., Holmans P., Nikolov I., Pahwa J.S., Green E., Owen M.J., O'Donovan M.C. Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk. Mol. Psychiatry 2009, 14:252-260.
42. Nieuwenhuis I.L., Takashima A. The role of the ventromedial prefrontal cortex in memory consolidation. Behav. Brain Res. 2011, 218:325-334.
43. Nyegaard M., Demontis D., Foldager L., Hedemand A., Flint T.J., Sorensen K.M., Andersen P.S., Nordentoft M., Werge T., Pedersen C.B., Hougaard D.M., Mortensen P.B., Mors O., Borglum A.D. CACNA1C (rs1006737) is associated with schizophrenia. Mol. Psychiatry 2010, 15:119-121.
44. Ongur D., Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb. Cortex 2000, 10:206-219.
45. Paulus F.M., Bedenbender J., Krach S., Pyka M., Krug A., Sommer J., Mette M., Nothen M.M., Witt S.H., Rietschel M., Kircher T., Jansen A. Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity. Hum. Brain Mapp. 2014, 35:1190-1200.
46. Phillips M.L., Ladouceur C.D., Drevets W.C. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol. Psychiatry 2008, 13(829):833-857.
47. Purcell S.M., Wray N.R., Stone J.L., Visscher P.M., O'Donovan M.C., Sullivan P.F., Sklar P. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
48. Radley J.J., Rocher A.B., Rodriguez A., Ehlenberger D.B., Dammann M., McEwen B.S., Morrison J.H., Wearne S.L., Hof P.R. Repeated stress alters dendritic spine morphology in the rat medial prefrontal cortex. J. Comp. Neurol. 2008, 507:1141-1150.
49. Ragland J.D., Laird A.R., Ranganath C., Blumenfeld R.S., Gonzales S.M., Glahn D.C. Prefrontal activation deficits during episodic memory in schizophrenia. Am. J. Psychiatry 2009, 166:863-874.
50. Ripke S., Sanders A.R., Kendler K.S., Levinson D.F., Sklar P., Holmans P.A., Lin D.Y., Duan J., Ophoff R.A., Andreassen O.A., Scolnick E., Cichon S., St Clair D., Corvin A., Gurling H., Werge T., Rujescu D., Blackwood D.H., Pato C.N., Malhotra A.K., Purcell S., Dudbridge F., Neale B.M., Rossin L., Visscher P.M., Posthuma D., Ruderfer D.M., Fanous A., Stefansson H., Steinberg S., Mowry B.J., Golimbet V., De Hert M., Jonsson E.G., Bitter I., Pietilainen O.P., Collier D.A., Tosato S., Agartz I., Albus M., Alexander M., Amdur R.L., Amin F., Bass N., Bergen S.E., Black D.W., Borglum A.D., Brown M.A., Bruggeman R., Buccola N.G., Byerley W.F., Cahn W., Cantor R.M., Carr V.J., Catts S.V., Choudhury K., Cloninger C.R., Cormican P., Craddock N., Danoy P.A., Datta S., de Haan L., Demontis D., Dikeos D., Djurovic S., Donnelly P., Donohoe G., Duong L., Dwyer S., Fink-Jensen A., Freedman R., Freimer N.B., Friedl M., Georgieva L., Giegling I., Gill M., Glenthoj B., Godard S., Hamshere M., Hansen M., Hansen T., Hartmann A.M., Henskens F.A., Hougaard D.M., Hultman C.M., Ingason A., Jablensky A.V., Jakobsen K.D., Jay M., Jurgens G., Kahn R.S., Keller M.C., Kenis G., Kenny E., Kim Y., Kirov G.K., Konnerth H., Konte B., Krabbendam L., Krasucki R., Lasseter V.K., Laurent C., Lawrence J., Lencz T., Lerer F.B., Liang K.Y., Lichtenstein P., Lieberman J.A., Linszen D.H., Lonnqvist J., Loughland C.M., Maclean A.W., Maher B.S., Maier W., Mallet J., Malloy P., Mattheisen M., Mattingsdal M., McGhee K.A., McGrath J.J., McIntosh A., McLean D.E., McQuillin A., Melle I., Michie P.T., Milanova V., Morris D.W., Mors O., Mortensen P.B., Moskvina V., Muglia P., Myin-Germeys I., Nertney D.A., Nestadt G., Nielsen J., Nikolov I., Nordentoft M., Norton N., Nothen M.M., O'Dushlaine C.T., Olincy A., Olsen L., O'Neill F.A., Orntoft T.F., Owen M.J., Pantelis C., Papadimitriou G., Pato M.T., Peltonen L., Petursson H., Pickard B., Pimm J., Pulver A.E., Puri V., Quested D., Quinn E.M., Rasmussen H.B., Rethelyi J.M., Ribble R., Rietschel M., Riley B.P., Ruggeri M., Schall U., Schulze T.G., Schwab S.G., Scott R.J., Shi J., Sigurdsson E., Silverman J.M., Spencer C.C., Stefansson K., Strange A., Strengman E., Stroup T.S., Suvisaari J., Terenius L., Thirumalai S., Thygesen J.H., Timm S., Toncheva D., van den Oord E., van Os J., van Winkel R., Veldink J., Walsh D., Wang A.G., Wiersma D., Wildenauer D.B., Williams H.J., Williams N.M., Wormley B., Zammit S., Sullivan P.F., O'Donovan M.C., Daly M.J., Gejman P.V. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 2011, 43:969-976.
51. Roussos P., Giakoumaki S.G., Georgakopoulos A., Robakis N.K., Bitsios P. The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males. Bipolar Disord. 2011, 13:250-259.
52. Ruderfer D.M., Fanous A.H., Ripke S., McQuillin A., Amdur R.L., Gejman P.V., O'Donovan M.C., Andreassen O.A., Djurovic S., Hultman C.M., Kelsoe J.R., Jamain S., Landen M., Leboyer M., Nimgaonkar V., Nurnberger J., Smoller J.W., Craddock N., Corvin A., Sullivan P.F., Holmans P., Sklar P., Kendler K.S. Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol. Psychiatry 2013, (in press). 10.1038/mp.2013.138.
53. Savitz J., Drevets W.C. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci. Biobehav. Rev. 2009, 33:699-771.
54. Sklar P., Smoller J.W., Fan J., Ferreira M.A., Perlis R.H., Chambert K., Nimgaonkar V.L., McQueen M.B., Faraone S.V., Kirby A., de Bakker P.I., Ogdie M.N., Thase M.E., Sachs G.S., Todd-Brown K., Gabriel S.B., Sougnez C., Gates C., Blumenstiel B., Defelice M., Ardlie K.G., Franklin J., Muir W.J., McGhee K.A., MacIntyre D.J., McLean A., VanBeck M., McQuillin A., Bass N.J., Robinson M., Lawrence J., Anjorin A., Curtis D., Scolnick E.M., Daly M.J., Blackwood D.H., Gurling H.M., Purcell S.M. Whole-genome association study of bipolar disorder. Mol. Psychiatry 2008, 13:558-569.
55. Sklar P., Ripke S., Scott L.J., Andreassen O.A., Cichon S., Craddock N., Edenberg H.J., Nurnberger J.I., Rietschel M., Blackwood D., Corvin A., Flickinger M., Guan W., Mattingsdal M., McQuillin A., Kwan P., Wienker T.F., Daly M., Dudbridge F., Holmans P.A., Lin D., Burmeister M., Greenwood T.A., Hamshere M.L., Muglia P., Smith E.N., Zandi P.P., Nievergelt C.M., McKinney R., Shilling P.D., Schork N.J., Bloss C.S., Foroud T., Koller D.L., Gershon E.S., Liu C., Badner J.A., Scheftner W.A., Lawson W.B., Nwulia E.A., Hipolito M., Coryell W., Rice J., Byerley W., McMahon F.J., Schulze T.G., Berrettini W., Lohoff F.W., Potash J.B., Mahon P.B., McInnis M.G., Zollner S., Zhang P., Craig D.W., Szelinger S., Barrett T.B., Breuer R., Meier S., Strohmaier J., Witt S.H., Tozzi F., Farmer A., McGuffin P., Strauss J., Xu W., Kennedy J.L., Vincent J.B., Matthews K., Day R., Ferreira M.A., O'Dushlaine C., Perlis R., Raychaudhuri S., Ruderfer D., Hyoun P.L., Smoller J.W., Li J., Absher D., Thompson R.C., Meng F.G., Schatzberg A.F., Bunney W.E., Barchas J.D., Jones E.G., Watson S.J., Myers R.M., Akil H., Boehnke M., Chambert K., Moran J., Scolnick E., Djurovic S., Melle I., Morken G., Gill M., Morris D., Quinn E., Muhleisen T.W., Degenhardt F.A., Mattheisen M., Schumacher J., Maier W., Steffens M., Propping P., Nothen M.M., Anjorin A., Bass N., Gurling H., Kandaswamy R., Lawrence J., McGhee K., McIntosh A., McLean A.W., Muir W.J., Pickard B.S., Breen G., St Clair D., Caesar S., Gordon-Smith K., Jones L., Fraser C., Green E.K., Grozeva D., Jones I.R., Kirov G., Moskvina V., Nikolov I., O'Donovan M.C., Owen M.J., Collier D.A., Elkin A., Williamson R., Young A.H., Ferrier I.N., Stefansson K., Stefansson H., Thornorgeirsson T., Steinberg S., Gustafsson O., Bergen S.E., Nimgaonkar V., Hultman C., Landen M., Lichtenstein P., Sullivan P., Schalling M., Osby U., Backlund L., Frisen L., Langstrom N., Jamain S., Leboyer M., Etain B., Bellivier F., Petursson H., Sigur Sson E., Muller-Mysok B., Lucae S., Schwarz M., Schofield P.R., Martin N., Montgomery G.W., Lathrop M., Oskarsson H., Bauer M., Wright A., Mitchell P.B., Hautzinger M., Reif A., Kelsoe J.R., Purcell S.M. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 2011, 43:977-983.
56. Smoller J.W., Craddock N., Kendler K., Lee P.H., Neale B.M., Nurnberger J.I., Ripke S., Santangelo S., Sullivan P.F. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379.
57. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. Am. J. Psychiatry 2010, 167:1178-1193.
58. Tesli M., Egeland R., Sonderby I.E., Haukvik U.K., Bettella F., Hibar D.P., Thompson P.M., Rimol L.M., Melle I., Agartz I., Djurovic S., Andreassen O.A. No evidence for association between bipolar disorder risk gene variants and brain structural phenotypes. J. Affect. Disord. 2013, 151:291-297.
59. Tesli M., Skatun K.C., Ousdal O.T., Brown A.A., Thoresen C., Agartz I., Melle I., Djurovic S., Jensen J., Andreassen O.A. CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls. PLoS One 2013, 8:e56970.
60. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 1987, 44:660-669.
61. White J.A., McKinney B.C., John M.C., Powers P.A., Kamp T.J., Murphy G.G. Conditional forebrain deletion of the l-type calcium channel Ca V 1.2 disrupts remote spatial memories in mice. Learn. Mem. 2008, 15:1-5.
62. Williams H.J., Craddock N., Russo G., Hamshere M.L., Moskvina V., Dwyer S., Smith R.L., Green E., Grozeva D., Holmans P., Owen M.J., O'Donovan M.C. Most genome-wide significant susceptibility loci for schizophrenia and bipolar disorder reported to date cross-traditional diagnostic boundaries. Hum. Mol. Genet. 2011, 20:387-391.
63. Wolf C., Mohr H., Schneider-Axmann T., Reif A., Wobrock T., Scherk H., Kraft S., Schmitt A., Falkai P., Gruber O. CACNA1C genotype explains interindividual differences in amygdala volume among patients with schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2014, 264:93-102.
64. Woodside B.L., Borroni A.M., Hammonds M.D., Teyler T.J. NMDA receptors and voltage-dependent calcium channels mediate different aspects of acquisition and retention of a spatial memory task. Neurobiol. Learn. Mem. 2004, 81:105-114.
65. Wray N.R., Pergadia M.L., Blackwood D.H., Penninx B.W., Gordon S.D., Nyholt D.R., Ripke S., MacIntyre D.J., McGhee K.A., Maclean A.W., Smit J.H., Hottenga J.J., Willemsen G., Middeldorp C.M., de Geus E.J., Lewis C.M., McGuffin P., Hickie I.B., van den Oord E.J., Liu J.Z., Macgregor S., McEvoy B.P., Byrne E.M., Medland S.E., Statham D.J., Henders A.K., Heath A.C., Montgomery G.W., Martin N.G., Boomsma D.I., Madden P.A., Sullivan P.F. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol. Psychiatry 2012, 17:36-48.